Valuation: Cello Health plc

Market Cap 179M 157M 145M 135M 254M 16.91B 259M 1.73B 673M 8.34B 672M 657M 29.07B P/E 2018
18.1x
P/E 2019 -155x
Enterprise Value 182M 160M 147M 137M 259M 17.25B 264M 1.77B 686M 8.51B 685M 670M 29.65B EV / Sales 2018
0.66x
EV / Sales 2019 0.88x
Free-Float
-
Yield 2018
3.47%
Yield 2019 1.6%
Manager TitleAgeSince
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 51 2020-08-12
Director/Board Member 47 2023-12-14
Date Insider Type Main position Quantity % Market Cap.
20-03-29Free

Founder

495,000 0.4656%
20-03-29Free 80,000 0.0752%
20-03-29Free

Chief Operating Officer

265,000 0.2492%

Financials

2018 2019
Net sales 166M 145M 134M 125M 235M 15.66B 239M 1.6B 623M 7.73B 622M 608M 26.91B 167M 146M 135M 126M 237M 15.77B 241M 1.62B 628M 7.78B 627M 613M 27.11B
Net income 6.62M 5.79M 5.35M 4.99M 9.4M 626M 9.57M 64.14M 24.9M 309M 24.86M 24.31M 1.08B -943K -825K -762K -711K -1.34M -89.16M -1.36M -9.14M -3.55M -44M -3.54M -3.46M -153M
Net Debt -6.34M -5.55M -5.12M -4.78M -9M -600M -9.17M -61.46M -23.86M -296M -23.82M -23.29M -1.03B 3.58M 3.13M 2.89M 2.7M 5.08M 338M 5.17M 34.67M 13.46M 167M 13.44M 13.14M 581M
Logo Cello Health plc
Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.
Employees
-
Sector
-